Forskning ved Københavns Universitet - Københavns Universitet

Forside

Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Hans-Jürgen Stellbrink
  • Chloe Orkin
  • Jose Ramon Arribas
  • Juliet Compston
  • Gerstoft, Jan
  • Eric Van Wijngaerden
  • Adriano Lazzarin
  • Giuliano Rizzardini
  • Herman G Sprenger
  • John D. C. Lambert
  • Gunta Sture
  • David Leather
  • Sara Hughes
  • Patrizia Zucchi
  • Helen Pearce
  • ASSERT Study Group
Abacavir-lamivudine and tenofovir DF-emtricitabine fixed-dose combinations are commonly used as first-line antiretroviral therapies. However, few studies have comprehensively compared their relative safety profiles.
OriginalsprogEngelsk
TidsskriftClinical Infectious Diseases
Vol/bind51
Udgave nummer8
Sider (fra-til)963-72
Antal sider10
ISSN1058-4838
DOI
StatusUdgivet - 15 okt. 2010

ID: 34052069